Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Capital Expenditures (2016 - 2025)

Neogen (NEOG) has 16 years of Capital Expenditures data on record, last reported at $11.7 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 31.99% year-over-year to $11.7 million; the TTM value through Nov 2025 reached $84.7 million, down 24.37%, while the annual FY2025 figure was $104.6 million, 6.13% down from the prior year.
  • Capital Expenditures reached $11.7 million in Q4 2025 per NEOG's latest filing, down from $24.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $38.4 million in Q3 2024 and bottomed at $1.3 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $17.9 million, with a median of $15.6 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: tumbled 69.52% in 2021, then skyrocketed 903.55% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $3.9 million in 2021, then soared by 207.26% to $12.1 million in 2022, then soared by 101.69% to $24.4 million in 2023, then fell by 29.73% to $17.2 million in 2024, then crashed by 31.99% to $11.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $11.7 million in Q4 2025, $24.0 million in Q3 2025, and $16.1 million in Q2 2025.